NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

Your inability to understand how biotech and the approval of a drug for a certain cancer indication works does not surprise me at all.
You already showed to not know much about the workings of an RA approval process.
NWBO should count its lucky stars if it gets FDA-approved for GBM n and r (which I think is possible but not certain) in the US the way the DCVAXL trial SAP has been set up.

A universal cancer vaccine can only be proven with multi-medical trials which NWBO has shown not to be capable of conducting.
Several immu biotech companies actually are in multi-medical trials and have already had RA-approved indications. That is because these biotech companies are well-led by management that delivers shareholders AND patient value. Not so much this inept management.

The rest is just wishful thinking fantasy.